Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Trop Pediatr ; 68(4)2022 06 06.
Article in English | MEDLINE | ID: mdl-35674266

ABSTRACT

BACKGROUND: The prompt and accurate aetiological diagnosis of childhood pneumonia remains a challenge, especially in sub-Saharan Africa (SSA) because of limited resources for disease management. OBJECTIVE: To review existing diagnostics for childhood pneumonia and potential modalities available to differentiate between bacterial and viral aetiologies in SSA. METHODS: Online databases were searched for relevant articles published between January 2010 and December 2020 regarding childhood pneumonia diagnosis, conducted in SSA in children less than 18 years of age. The 2020 PRISMA checklist was utilized in appraising the selected studies and the QUADAS-2 tool was employed to assess the risk of bias in each of the studies selected. RESULTS: A total of 1542 study titles and abstracts were screened following which 45 studies (39 on childhood pneumonia diagnostics and 6 on discriminating between bacterial and viral childhood pneumonia) were selected for review. Microbiological investigations (79.7%) constituted the most utilized index tests with blood-related specimen (32.8%) being the most utilized specimen. The most performed index diagnostic modality was polymerase chain reaction (PCR) (53.1%). The commonest reference gold standard technique was based on clinical diagnosis of the disease (46.2%). Only six studies in SSA attempted at using serum biomarkers, either singly or in combination to distinguish between aetiologies with use of combined biomarkers showing promise. CONCLUSION: Microbiological investigations are the most employed diagnostic methods for childhood pneumonia in SSA. More studies are required to evaluate the potential use of serum biomarkers; either singly or in combination with the goal of discriminating bacterial and viral childhood pneumonia.


Childhood pneumonia remains a disease of global health significance, contributing greatly to childhood morbidity and mortality especially in SSA. The effective management of the disease anchors on prompt diagnosis and identification of the likely aetiologic agent in order to guide appropriate therapeutic interventions. Though a global challenge, the diagnosis of the disease remains a major concern particularly in low- and middle-income settings given the limited resources. This study aimed at systematically reviewing childhood pneumonia diagnostics in SSA which is a high burden area with limited resources. The review also aimed at identifying potential modalities available to differentiate between bacterial and viral aetiologies as these findings will have implications on antimicrobial stewardship in the region. Following a review of three online databases, microbiological investigations (79.7%) constituted the most utilized index tests in SSA while blood-related specimen (32.8%) being the most utilized specimen. There was no study in the region assessing the potential usefulness of radiological modalities like lung ultrasonography for childhood pneumonia diagnostics which emphasizes a need for further research in that regard given its non-invasive nature and diagnostic validity from research carried out in more developed countries. Furthermore, only six studies aimed at discriminating bacterial or viral aetiology in the region which is limited and is an area for further research.


Subject(s)
Checklist , Pneumonia , Africa South of the Sahara/epidemiology , Child , Humans , Pneumonia/diagnosis
2.
Pan Afr Med J ; 38: 24, 2021.
Article in English | MEDLINE | ID: mdl-33777292

ABSTRACT

INTRODUCTION: Latent Tuberculosis Infection (LTBI) screening is recommended for individuals with a known risk factor for progression to active disease especially in the setting of HIV infection. This will ensure early diagnosis and prompt treatment. The purpose of our study was to compare tuberculin skin test (TST) with Interferon Gamma Release Assay (IGRA) in the diagnosis of LTBI among patients with known HIV infection at University of Ilorin Teaching Hospital (UITH), Ilorin. METHODS: this was a hospital based cross-sectional study at the Highly Active Antiretroviral therapy (HAART) Clinic and medical wards of the University of Ilorin Teaching Hospital, Ilorin, Nigeria. A total of 282 consenting patients with HIV infection were recruited. Sociodemographic and clinical information was obtained using a well-structured questionnaire. The screening for LTBI was done using Tuberculin skin test (TST) and Interferon Gamma release assay (IGRA). RESULTS: the prevalence of LTBI among HIV infected patients was 40.6% and 53.1% using TST and QFT-IT respectively, while the overall prevalence considering positivity to either of the test was 66%. There was mild agreement (κ: 0.218) between TST and QFT-IT in the diagnosis of LTBI among patients with HIV infection. The association between CD4 count and TST was not statistically significant (p value = 0.388) but there was strong association between CD4 cell count and QFT results (p = 0.001). CONCLUSION: the prevalence of LTBI is quite high among patients with HIV infection in our locality. There is a need to encourage screening of at-risk individuals to forestall the morbidity and mortality associated with TB in this population.


Subject(s)
HIV Infections/complications , Interferon-gamma Release Tests/methods , Latent Tuberculosis/diagnosis , Tuberculin Test/methods , Adult , Aged , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Cross-Sectional Studies , Female , HIV Infections/drug therapy , Humans , Latent Tuberculosis/epidemiology , Male , Mass Screening/methods , Middle Aged , Nigeria , Prevalence , Risk Factors , Surveys and Questionnaires , Young Adult
3.
Niger Postgrad Med J ; 27(3): 163-170, 2020.
Article in English | MEDLINE | ID: mdl-32687114

ABSTRACT

BACKGROUND: Pulmonary tuberculosis (PTB) contributes significantly to morbidity and mortality worldwide, and despite microbiological cure for the disease, many patients still demonstrate residual respiratory symptoms and spirometric abnormalities. AIM AND OBJECTIVES: The study aimed at identifying the prevalence, pattern and factors associated with spirometric abnormalities in patients successfully treated for PTB in Ilorin, Nigeria. MATERIALS AND METHODS: This was a hospital-based cross-sectional study at the pulmonary outpatient clinics of the University of Ilorin Teaching Hospital and Kwara State Specialist Hospital, Sobi, Ilorin. A total of 308 consenting patients who had been certified microbiologically cured for bacteriologically confirmed PTB in the preceding 3 years had assessment of residual pulmonary symptoms, spirometry and plain chest radiograph. RESULTS: The prevalence of abnormal spirometry following treatment for PTB was 72.1% (confidence interval: 0.6682-0.7695), with restrictive pattern being the predominant abnormality (42.2%). Over half of the patients (56.5%) had at least one residual respiratory symptom. The significant predictors of abnormal spirometry were PTB retreatment (adjusted odds ratio [aOR] = 6.918; P = 0.012), increasing modified Medical Research Council dyspnoea scores (aOR = 7.935; P = 0.008) and increasing radiologic scores (aOR = 4.679; P ≤ 0.001) after treatment. CONCLUSION: There is significant residual lung function impairment in majority of the individuals successfully treated for PTB in Ilorin. This highlights the need for spirometric assessment and follow-up after treatment.


Subject(s)
Antitubercular Agents/therapeutic use , Lung/physiopathology , Spirometry/statistics & numerical data , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/drug therapy , Adult , Cross-Sectional Studies , Female , Humans , Lung/microbiology , Male , Nigeria/epidemiology , Prevalence , Respiratory Function Tests/methods , Tuberculosis, Pulmonary/epidemiology
4.
Afr Health Sci ; 20(4): 1655-1668, 2020 Dec.
Article in English | MEDLINE | ID: mdl-34394226

ABSTRACT

BACKGROUND: The optimal management of community acquired pneumonia (CAP) depends on the clinical and microbiological profile in the locality. OBJECTIVES: To determine the clinical and microbiological profile of patients admitted with CAP in Ilorin, Nigeria. METHODS: One hundred and two consenting consecutively selected patients with clinical and radiologic confirmation of CAP were recruited in 12 months. The socio-demographic, physical examination and laboratory/radiologic parameters were documented in a questionnaire. Microbiological evaluation of their sputum was done and blood samples were taken for complete blood count, culture, serum urea and serological evaluation for atypical bacteria and some viral pathogens. RESULTS: CAP constituted 5.9% of the total medical admissions during the one-year study period. The mean age of the patients was 49 ± 22 years with the largest frequency in those aged 65 years and above. The commonest symptoms were shortness of breath (96.1%) and cough (94.1%), with a median duration of 3 days from symptom onset to admission. Systemic hypertension was the commonest comorbid illness (25/102; 24.5%). Klebsiella pneumoniae was the predominant pathogen isolated (20/102; 28.1%). The susceptible antibiotics were Imipenem, Ceftazidime and Ceftriaxone. Intra-hospital mortality was 17.6%. CURB - 65 score of ≥ 2 and the presence of complications of CAP were the independent predictors of mortality. CONCLUSION: CAP constitutes a significant disease burden in Ilorin, Nigeria. Typical bacteria accounted for over half of the pathogens isolated from the patients with gram negative agents predominating. This highlights a possible shift in the microbiological profile which could guide empirical treatment.


Subject(s)
Community-Acquired Infections/epidemiology , Pneumonia, Bacterial/microbiology , Pneumonia, Viral/virology , Adolescent , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/drug therapy , Cough/etiology , Dyspnea/etiology , Hospital Mortality , Humans , Inpatients , Male , Middle Aged , Nigeria/epidemiology , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/drug therapy , Pneumonia, Viral/diagnosis , Pneumonia, Viral/drug therapy , Prospective Studies , Sputum/microbiology
5.
Reumatologia ; 55(5): 261-264, 2017.
Article in English | MEDLINE | ID: mdl-29332966

ABSTRACT

Löfgren's syndrome (LS) is a variant of sarcoidosis characterised by the triad of erythema nodosum (EN), radiographic bilateral hilar adenopathy, and arthralgia/arthritis. Like all cases of sarcoidosis, it is of unknown aetiology and may constitute a diagnostic difficulty in the ambiguous phenotype. Löfgren's syndrome is associated with a good prognosis and commonly undergoes spontaneous remission within four months. However, the co-existence of multiple good and adverse prognostic factors in a patient may call for guarded expectation. Sarcoidosis is generally more prevalent among people of African descent, but the vast majority of the literature on sarcoidosis are from the western hemisphere. Löfgren's syndrome has been rarely documented in West Africans despite the availability of some reports of sarcoidosis in the region. We present a case of a Nigerian woman with LS that started out as isolated EN, which was ignored for months until the onset of florid pulmonary and systemic symptoms.

SELECTION OF CITATIONS
SEARCH DETAIL